TY - JOUR
T1 - Does baseline PTH influence recovery of bone mineral density, trabecular bone score and bone turnover markers? A prospective study following curative parathyroidectomy in primary hyperparathyroidism
AU - Shetty, Shrinath
AU - Cherian, Kripa Elizabeth
AU - Shetty, Sahana
AU - Kapoor, Nitin
AU - Jebasingh, Felix K.
AU - Cherian, Anish
AU - Hephzibah, Julie
AU - Chandramohan, Anuradha
AU - John, Reetu Amirta
AU - Asha, Hesarghatta S.
AU - Paul, Mazhuvanchary Jacob
AU - Manipadam, Marie Therese
AU - Abraham, Deepak Thomas
AU - Thomas, Nihal
AU - Paul, Thomas Vizhalil
N1 - Publisher Copyright:
© 2020 AACE.
PY - 2020/12
Y1 - 2020/12
N2 - Objective: This prospective study was carried out to assess trabecular bone score, bone mineral density (BMD), and bone biochemistry in Indian subjects with symptomatic primary hyperparathyroidism (PHPT), and to study the influence of baseline parathyroid hormone (PTH) on recovery of these parameters following curative surgery. Methods: This was a 2-year prospective study conducted at a tertiary care centre in southern India. Baseline assessment included demographic details, mode of presentation, bone mineral biochemistry, BMD, trabecular bone score (TBS), and bone turnover markers (BTMs). These parameters were reassessed at the end of the first and second years following curative parathyroid surgery. Results: Fifty-one subjects (32 men and 19 women) with PHPT who had undergone curative parathyroidectomy were included in this study. The mean (SD) age was 44.6 (13.7) years. The TBS, BTMs, and BMD at lumbar spine and forearm were significantly worse at baseline in subjects with higher baseline PTH (≥250 pg/mL) when compared to the group with lower baseline PTH (<250 pg/ mL). At the end of 2 years, the difference between high versus low PTH groups (mean ± SD) persisted only for forearm BMD (0.638 ± 0.093 versus 0.698 ± 0.041 g/ cm2; P = .01). However, on follow-up visits in the first and second year after curative parathyroidectomy, there was no significant difference in BTMs, BMD at the femoral neck, lumbar spine, and TBS between the 2 groups stratified by baseline PTH. Conclusion: The BMD at the forearm remained significantly worse in individuals with high baseline PTH even at 2 years after surgery, while other parameters including TBS improved significantly from baseline.
AB - Objective: This prospective study was carried out to assess trabecular bone score, bone mineral density (BMD), and bone biochemistry in Indian subjects with symptomatic primary hyperparathyroidism (PHPT), and to study the influence of baseline parathyroid hormone (PTH) on recovery of these parameters following curative surgery. Methods: This was a 2-year prospective study conducted at a tertiary care centre in southern India. Baseline assessment included demographic details, mode of presentation, bone mineral biochemistry, BMD, trabecular bone score (TBS), and bone turnover markers (BTMs). These parameters were reassessed at the end of the first and second years following curative parathyroid surgery. Results: Fifty-one subjects (32 men and 19 women) with PHPT who had undergone curative parathyroidectomy were included in this study. The mean (SD) age was 44.6 (13.7) years. The TBS, BTMs, and BMD at lumbar spine and forearm were significantly worse at baseline in subjects with higher baseline PTH (≥250 pg/mL) when compared to the group with lower baseline PTH (<250 pg/ mL). At the end of 2 years, the difference between high versus low PTH groups (mean ± SD) persisted only for forearm BMD (0.638 ± 0.093 versus 0.698 ± 0.041 g/ cm2; P = .01). However, on follow-up visits in the first and second year after curative parathyroidectomy, there was no significant difference in BTMs, BMD at the femoral neck, lumbar spine, and TBS between the 2 groups stratified by baseline PTH. Conclusion: The BMD at the forearm remained significantly worse in individuals with high baseline PTH even at 2 years after surgery, while other parameters including TBS improved significantly from baseline.
UR - https://www.scopus.com/pages/publications/85098112278
UR - https://www.scopus.com/inward/citedby.url?scp=85098112278&partnerID=8YFLogxK
U2 - 10.4158/EP-2020-0148
DO - 10.4158/EP-2020-0148
M3 - Article
C2 - 33471736
AN - SCOPUS:85098112278
SN - 1530-891X
VL - 26
SP - 1442
EP - 1450
JO - Endocrine Practice
JF - Endocrine Practice
IS - 12
ER -